Drug-Trial Software Maker Clario Files Confidentially for IPO

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Technology Technology Headlines News

Technology Technology Latest News,Technology Technology Headlines

Clario, a provider of software to help drugmakers advance treatments through clinical trials, has filed confidentially for an initial public offering and is targeting a valuation of more than $10 billion, people familiar with the matter said.

Drug-Trial Software Maker Clario Files Confidentially for IPOFed’s Cook Says Rate Cut Needed at Some Point But Timing UnclearKenyan President Deploys Military to Halt ‘Treasonous’ ProtestsGlen Point’s Neil Phillips Spared US Prison for FX ManipulationApollo’s Zito Says Bank Risk Deals Are the ‘Investment du Jour’NY’s MTA to Detail How Toll Pause Is Squeezing Operating BudgetBTG to Triple European Real Estate Investments to €1 BillionFedEx Results to Test Torrid Run in Transportation StocksHow...

Fed’s Bowman warns of upside risks to inflation, not time to cut'We’re expecting modest disinflation': Manulife investment strategist on Bank of Canada outlookCanada to curb China EV imports as Trudeau responds to Biden moveThe Daily Chase: Target takes aim at third-party selling with Shopify partnershipCanada's China EV tariff plan draws debate over best approachInflation, geopolitics weighing on tourism industryCollege clampdown on track to halve student arrivals to CanadaThe...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in TECHNOLOGY

Technology Technology Latest News, Technology Technology Headlines